Search results
Results from the WOW.Com Content Network
According to the North Carolina Biotechnology Center, North Carolina is home to 528 biotechnology companies that provide 57,000 jobs and $1.92 billion in taxes for state and local government. [3] Employment in the industry has grown 4.1% from 2008 to 2010, when other industries shed thousands of jobs. [ 4 ]
The North Carolina Biotechnology Center is a non-profit, public-private partnership organization located in Research Triangle Park (North Carolina, United States).Founded in 1984 by the North Carolina General Assembly, it was the first state-sponsored biotechnology initiative in the United States, merging the interests of the academic private and public sectors. [1]
For the second time in eight days, the Eastern North Carolina county of Wilson is celebrating the promise of a new pharmaceutical facility. Last week, the manufacturer of the cold and flu medicine ...
This is a list of major companies and organizations in the Charlotte metropolitan area, through corporate or subsidiary headquarters or through significant operational and employment presence in and around the American city of Charlotte, North Carolina. The Charlotte metropolitan area is home to seven Fortune 500 companies, numbers in italics ...
For premium support please call: 800-290-4726 more ways to reach us
Johnston Community College (JCC) is a public community college in Smithfield, North Carolina. It is located 30 miles (48 km) east of Raleigh, near the junction of I-95 and US 70. It is located 30 miles (48 km) east of Raleigh, near the junction of I-95 and US 70.
Wake Forest Biotech Building. Innovation Quarter in Winston-Salem, North Carolina, formerly Wake Forest Innovation Quarter, is an innovation district focused on research, business, and education in biomedical science, information technology, digital media, clinical services, and advanced materials. [1]
Precision is in the process of developing multiple candidates targeting non-Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), [4] [19] and multiple myeloma. [23] The company's lead candidate targeting CD19, PBCAR0191, [19] received orphan drug designation from the U.S. Food and Drug Administration for the treatment of ALL and mantle cell lymphoma, an aggressive subtype of non-Hodgkin ...